Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives

The shared pathobiological mechanisms driving progressive fibrosis in interstitial lung diseases (ILDs) remain unclear. Neutrophils, the most common immune cells in the human body, contain an extensive array of proteinases that are important for cell function, including tissue repair and remodelling...

Full description

Saved in:

Bibliographic Details
Main Authors:	Louise Elizabeth Crowley, Robert Andrew Stockley, David Richard Thickett, Davinder Dosanjh, Aaron Scott, Dhruv Parekh
Format:	Article
Language:	English
Published:	European Respiratory Society 2024-11-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/content/33/174/240139.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis
by: Dhruv Parekh, et al.
Published: (2021-01-01)

COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills
by: Sebastian T Lugg, et al.
Published: (2021-01-01)

Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers
by: Karan R. Chadda, et al.
Published: (2024-11-01)

Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease
by: Mengjiao Xu, et al.
Published: (2025-01-01)

Investigates the Role of PANoptosis in Idiopathic Pulmonary Fibrosis and Potential Therapeutic Targets
by: Xiang Y, et al.
Published: (2024-12-01)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
by: Stephanie Toth-Manikowski, et al.
Published: (2015-01-01)

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
by: Zhe Chen, et al.
Published: (2025-01-01)

Normalization of Cystic Fibrosis Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of Cystic Fibrosis MiceSummary
by: Callie E. Scull, et al.
Published: (2025-01-01)

From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach
by: Parham Shahidi, et al.
Published: (2024-11-01)

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
by: Christopher J. Ryerson, et al.
Published: (2016-01-01)

Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies
by: Vincenzo Rizza, et al.
Published: (2024-12-01)

Therapeutic potential of human stem cell-derived extracellular vesicles in idiopathic pulmonary fibrosis
by: Kyoung Soo Lee, et al.
Published: (2024-12-01)

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages
by: Kelly Carter, et al.
Published: (2024-12-01)

New Insights into the Pathophysiology of Mild Chronic Obstructive Pulmonary Disease
by: Jordan A Guenette
Published: (2014-01-01)

ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
by: Yuechong Xia, et al.
Published: (2024-12-01)

Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
by: Vishal Vyas, et al.
Published: (2019-03-01)

Acute therapeutic effects and pathophysiology of eosinophilic granulomatosis with polyangiitis neuropathy
by: Fumitaka Shimizu, et al.
Published: (2025-01-01)

Neutrophil Extracellular Trap Production in Patients with Colorectal Cancer In Vitro
by: J. J. R. Richardson, et al.
Published: (2017-01-01)

The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease
by: Claire Y Mou, et al.
Published: (2025-12-01)

Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
by: Kangchen Li, et al.
Published: (2025-01-01)

Dietary Flaxseed Oil Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats
by: Joshua Lawrenz, et al.
Published: (2012-01-01)

Commentary: Heart–brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential
by: Bupe Amon Kyelu, et al.
Published: (2025-01-01)

Exploiting the Zebrafish Model for Sepsis Research: Insights into Pathophysiology and Therapeutic Potentials
by: He J, et al.
Published: (2024-11-01)

Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience
by: Rahul Y Mahida, et al.
Published: (2020-09-01)

The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
by: Reyhaneh Niayesh-Mehr, et al.
Published: (2024-11-01)

Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective
by: Leslie Marisol Gonzalez-Hermosillo, et al.
Published: (2024-11-01)

Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
by: Dawei Yang, et al.
Published: (2012-01-01)

Vascular involvement in idiopathic pulmonary fibrosis
by: Michele Mondoni, et al.
Published: (2024-11-01)

Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Lee Fidler, et al.
Published: (2015-01-01)

TRAIL-Dependent Resolution of Pulmonary Fibrosis
by: David M. Habiel, et al.
Published: (2018-01-01)

Smoking and Pulmonary Fibrosis: Novel Insights
by: Katerina D. Samara, et al.
Published: (2011-01-01)

Editorial: Pulmonary fibrosis and endocrine factors
by: Pengxiu Cao, et al.
Published: (2024-11-01)

Neutrophil extracellular traps are associated with airways inflammation and increased severity of lung disease in cystic fibrosis
by: Sheonagh M. Law, et al.
Published: (2024-12-01)

Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies
by: Samuel Oluwadare Olalekan, et al.
Published: (2025-01-01)

Oxidative stress in diabetes mellitus and its complications: From pathophysiology to therapeutic strategies
by: Xingyu Chen, et al.
Published: (2025-01-01)

Pathophysiology /
by: Copstead, Lee Ellen
Published: (2013)

Objective measurement of cough in pulmonary fibrosis: a cohort study – ImpaCT
by: Jad Kebbe, et al.
Published: (2024-09-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis
by: Heather Maughan, et al.
Published: (2012-01-01)